Correction: A differential process mining analysis of COVID-19 management for cancer patients [0.03%]
纠正：关于COVID-19癌症患者管理的差分过程挖掘分析
Michel A Cuendet,Roberto Gatta,Alexandre Wicky et al.
Michel A Cuendet et al.
[This corrects the article DOI: 10.3389/fonc.2022.1043675.]. Keywords: COVID-19; clinical pathways; oncology...
Published Erratum
Frontiers in oncology. 2026 Mar 2:16:1777196. DOI:10.3389/fonc.2026.1777196 2026
Identifying key risk factors for thrombocytopenia in patients undergoing radical chemoradiotherapy for nasopharyngeal cancer: a retrospective study [0.03%]
鼻咽癌根治性同期放化疗患者血小板减少的风险因素分析：一项回顾性研究
Qiongling Huang,Xinyuan Luo,Baoling Li et al.
Qiongling Huang et al.
Introduction: In this study, we investigated the risk factors for thrombocytopenia in patients undergoing radical chemoradiotherapy for nasopharyngeal carcinoma (NPC). ...
Prognostic value of lymph node ratio after neoadjuvant chemotherapy for gastric cancer: a systematic review and meta-analysis [0.03%]
新辅助化疗后胃癌淋巴结比例的预后价值：系统回顾和 Meta 分析
Siyan Liu,Xiang Da,Lihong Shu et al.
Siyan Liu et al.
Background: The prognostic value of the lymph node ratio (LNR) in gastric cancer treated with neoadjuvant chemotherapy (NACT) remains unclear, as conventional pathological nodal assessment after neoadjuvant therapy may be...
A real-world 10-year follow-up analysis of survival and safety of CD20-targeted therapy in patients with Waldenstrom macroglobulinemia [0.03%]
利妥昔单抗类似物治疗瓦尔登斯特伦巨球蛋白血症的长期生存和安全性分析：真实世界队列10年随访研究
Hengming Zhang,Xufei Huang,Yirong Zhu et al.
Hengming Zhang et al.
Objective: To evaluate the long-term survival and safety outcomes of CD20-targeted chemoimmunotherapy regimens in patients with Waldenstrom macroglobulinemia (WM) in a real-world single-center cohort from China. ...
Role of urinary leukocytes in the risk stratification of prostate cancer using nonlinear stacking learning strategy: a bi-cohort diagnostic study [0.03%]
基于非线性堆叠学习策略的前列腺癌风险分层中尿液白细胞的作用：一项双队列诊断研究
Shou Xia,Zhenchun Ran,Mengzhe Cheng et al.
Shou Xia et al.
Objective: This study aimed to develop a non-linear stacking ensemble learning framework to evaluate the incremental diagnostic contribution of urinary leukocytes (UL) in prostate cancer (PCa) risk stratification, with a ...
Knowledge-based planning for intensity-modulated proton therapy of the breast and chest wall with regional lymph nodes: development, validation, and comparative evaluation of two models [0.03%]
基于知识的计划用于乳腺和胸部淋巴结区域的调强质子治疗：两种模型的发展、验证与比较研究
Parker Anderson,Yihang Xu,Robert Kaderka et al.
Parker Anderson et al.
Purpose: Knowledge-based planning (KBP) can improve efficiency and consistency in radiotherapy. In intensity-modulated proton therapy (IMPT) for breast cancer, particularly with regional lymph nodes, treatment planning re...
Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report [0.03%]
原发于前列腺的黏膜相关淋巴组织结外边缘区非霍奇金淋巴瘤1例报告
Xiaoru Gao,Xinru Wang,Xiangfei Wang et al.
Xiaoru Gao et al.
This report describes a clinically rare case of early-stage primary extranodal marginal zone B-cell lymphoma of the prostate. A 73-year-old male presented with urinary hesitancy. Physical examination revealed mild prostatic enlargement. Pro...
Patient-derived cell lines unveil COL1A2 as a predictor of docetaxel resistance in breast cancer [0.03%]
患者来源的细胞系揭示COL1A2是乳腺癌多西他赛耐药性的预测因子
Yuwei Gao,Rong Wang,Xiaowei Dou et al.
Yuwei Gao et al.
Introduction: Breast cancer is the most common malignant tumor among women worldwide and a major cause of cancer-related mortality. Chemoresistance presents a significant challenge in breast cancer therapy and is a primar...
Improving radiation therapy efficacy considering DNA repair, TP53 mutations, microscopic heterogeneity, and low- and high-dose apoptosis [0.03%]
考虑DNA修复、TP53突变、微观异质性及低剂量和高剂量凋亡的放疗增效研究
Anders Brahme
Anders Brahme
All radiation types produce δ -rays of about a ≈1 keV or less that can impart MGy doses to 10-nm-size volumes of DNA. These events can produce severe dual double-strand breaks (DDSB) at the periphery of nucleosomes in single events partic...
Commentary: LAT1 expression in head and neck cancer: a prognostic biomarker with potential relevance for BNCT [0.03%]
评论文章:头颈部肿瘤中的LAT1表达：BNCT相关预后生物标志物？
Xiaobing Liao,Yuanyu Zhu,Changqian Piao et al.
Xiaobing Liao et al.